The initial response to coronavirus disease 2019 (COVID-19) in Ontario included suspension of cancer screening programs and deferral of diagnostic procedures and many treatments.
Although the short-term impact of these measures on female cancers is well documented, few studies have assessed the mid- to long-term impacts.
